Filtered By:
Condition: Atrial Fibrillation
Management: Health Insurance

This page shows you your search results in order of relevance. This is page number 14.

Order by Relevance | Date

Total 264 results found since Jan 2013.

Major Adverse Cardiovascular Events in Korean Congenital Heart Disease Patients: A Nationwide Age- and Sex-Matched Case-Control Study
CONCLUSION: In conclusion, this nationwide study demonstrates that Korean patients with CHD have a high incidence of comorbidities, vascular events, and mortality. CHD has been established as an important predictor of cardiovascular events. Further studies are warranted to identify high-risk patients with CHD and related factors to prevent vascular events.PMID:36444542 | PMC:PMC9760894 | DOI:10.3349/ymj.2022.0111
Source: Yonsei Medical Journal - November 29, 2022 Category: Universities & Medical Training Authors: Jue Seong Lee Jin-Man Jung Jongun Choi Woo-Keun Seo Hong Ju Shin Source Type: research

Abstract 215: Use of Chronic Medications among Patients with Non-Valvular Atrial Fibrillation Session Title: Poster Session II
Conclusion: Patients with NVAF typically have other chronic conditions and a large proportion of these patients may be on treatment regimens that require taking medications more than once per day.
Source: Circulation: Cardiovascular Quality and Outcomes - June 2, 2014 Category: Cardiology Authors: Kocis, P. T., Liu, G., Makenbaeva, D., Trocio, J., Velott, D. L., Trainer, J. B., Leslie, D. L. Tags: Session Title: Poster Session II Source Type: research

Inpatient Case-Related Treatment Costs For Different Cardiovascular Diseases In Germany
The objective of this cost analysis was to quantify inpatient treatment costs for each diagnosis in Germany from the perspective of the statutory health insurance.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: P.K. Schädlich, S. Rosenfeld, S. Reindl, W. Kotowa Source Type: research

Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: A population-based cohort study.
CONCLUSION: Patients with AF are more vulnerable to non-traffic-, non-cancer-related bone fractures especially when with specified characteristics. For those with higher CHA2DS2-VASc scores, the use of anticoagulant but not antiplatelet agents could be associated with lower risk of such events. PMID: 26493861 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - October 19, 2015 Category: Internal Medicine Authors: Lai HC, Chien WC, Chung CH, Lee WL, Wu TJ, Wang KY, Liu CN, Liu TJ Tags: Eur J Intern Med Source Type: research

The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study
Conclusions Compared with patients not enrolled in the P4P program, P4P patients had lower risk of developing serious vascular complications. Our empirical findings provide evidence for the potential long-term benefit of P4P programs in reducing risks of macrovascular complications.
Source: Preventive Medicine - January 11, 2016 Category: Global & Universal Source Type: research

Incidence and Risk Factors for Atrial Fibrillation in Korea: the National Health Insurance Service Database (2002-2010).
CONCLUSION: Incidence of AF increased with age and was higher in men than in women. A larger proportion of AF events was attributable to hypertension than to other co-morbidities. PMID: 27482260 [PubMed]
Source: Korean Circulation Journal - August 4, 2016 Category: Cardiology Tags: Korean Circ J Source Type: research

Thromboembolic, Bleeding, and Mortality  Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
BackgroundIt is unclear whether the non –vitamin K antagonist oral anticoagulant agents rivaroxaban and dabigatran are superior to warfarin for efficacy and safety outcomes in Asians with nonvalvular atrial fibrillation (NVAF).ObjectivesThe aim of this study was to compare the risk for thromboembolic events, bleeding, and mortality associated with rivaroxaban and dabigatran versus warfarin in Asians with NVAF.MethodsA nationwide retrospective cohort study was conducted of consecutive patients with NVAF taking rivaroxaban (n  = 3,916), dabigatran (n = 5,921), or warfarin (n = 5,251) using data collected from the Taiwan...
Source: Journal of the American College of Cardiology - September 20, 2016 Category: Cardiology Source Type: research

Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians
Abstract: The HATCH score (hypertension , age>75 years , stroke or transient ischemic attack , chronic obstructive pulmonary disease , and heart failure ) was reported to be useful for predicting the progression of atrial fibrillation (AF) from paroxysmal to persistent or permanent AF for patients who participated in the Euro Heart Survey. The goal of the current study was to investigate whether the HATCH score was a useful scheme in predicting new-onset AF. Furthermore, we aimed to use the HATCH scoring system to estimate the individual risk in developing AF for patients with different comorbidities. We used the “Taiwan...
Source: Medicine - January 1, 2017 Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research

The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data.
CONCLUSION: During the last decade, AF-related hospitalization and outpatient clinic visits have increased with the increase of many other comorbidities, whereas the rate of anticoagulation did not improved. Although mortality in patients with AF showed a modest decrease from 2004 to 2013, proper anticoagulation therapy is warranted for the improvement of public health. PMID: 28154592 [PubMed - in process]
Source: Korean Circulation Journal - February 7, 2017 Category: Cardiology Tags: Korean Circ J Source Type: research

Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort
ConclusionThe TRAF cohort is the first population-based, whole-country cohort of AF epidemiology, quality of care and outcomes. It provides a unique opportunity to study the patterns, causes and impact of treatments on the incidence and outcomes of AF in a developing country.
Source: Europace - February 10, 2017 Category: Cardiology Source Type: research

A novel algorithm for identifying risk factors for rare events: Predicting transient ischemic attack in young patients with low-risk atrial fibrillation
Publication date: Available online 6 November 2017 Source:Journal of Applied Biomedicine Author(s): Chieh-Yu Liu, Hui-Chun Chen Identification of risk factors for transient ischemic attack (TIA) is crucial for patients with atrial fibrillation (AF). However, identifying risk factors in young patients with low-risk AF is difficult, because the incidence of TIA in such patients is very low, which would result in traditional multiple logistic regression not being able to successfully identify the risk factors in such patients. Therefore, a novel algorithm for identifying risk factors for TIA is necessary. We thus propose a n...
Source: Journal of Applied Biomedicine - November 7, 2017 Category: Biotechnology Source Type: research

Aplastic Anemia and Risk of Incident Atrial Fibrillation  - A Nationwide Cohort Study.
CONCLUSIONS: Patients with AA could have an elevated risk for AF. The mortality risk increased further for those who develop AF. PMID: 29459495 [PubMed - as supplied by publisher]
Source: Circulation Journal - February 16, 2018 Category: Cardiology Authors: Hu WS, Sung FC, Lin CL Tags: Circ J Source Type: research